key: cord-0785011-f7dy0fk8
authors: Giustarini, Daniela; Santucci, Annalisa; Bartolini, Desirée; Galli, Francesco; Rossi, Ranieri
title: The age-dependent decline of the extracellular thiol-disulfide balance and its role in SARS-CoV-2 infection
date: 2021-02-17
journal: Redox Biol
DOI: 10.1016/j.redox.2021.101902
sha: 72ad423e44ff04cde4e13ba0bf407eb33435d8fa
doc_id: 785011
cord_uid: f7dy0fk8

SARS–CoV-2 (COVID-19) infection can cause a severe respiratory distress syndrome. The risk of severe manifestations and mortality characteristically increase in the elderly and in the presence of non-COVID-19 comorbidity. We and others previously demonstrated that the low molecular weight (LMW) and protein thiol/disulfide ratio declines in human plasma with age and such decline is even more rapid in the case of inflammatory and premature aging diseases, which are also associated with the most severe complications of COVID-19 infection. The same decline with age of the LMW thiol/disulfide ratio observed in plasma appears to occur in the extracellular fluids of the respiratory tract and in association with many pulmonary diseases that characteristically reduce the concentrations and adaptive stress response of the lung glutathione. Early evidence in literature suggests that the thiol to disulfide balance of the COVID-19 spike protein and the ACE-2 receptor of host cells could influence the risk of infection and the severity of the disease, with a more oxidizing environment producing the worst prognosis. With this hypothesis paper we propose that the age-dependent decline of LMW thiol/disulfide ratio of the extracellular fluids, produces the oxidizing conditions of Cys residues that promote the physical (protein-protein) interaction of CoV-2 and the host cell in the airways. This redox-dependent interaction is expected to affect the risk of infection and the severity of the disease. The hypothesis can be verified in experimental models of in vitro CoV-2 infection and at the clinical level in that LMW thiols and protein thiolation can now be investigated with standardized, reliable and versatile laboratory protocols. Presenting the verification strategy of our hypothesis, we also discuss available nutritional and ancillary pharmacological strategies to intervene on the thiol/disulfide ratio of extracellular fluids of subjects at risk of infection and COVID-19 patients.

age-dependent disparities characterize the SARS-CoV-2 disease, with the aged having the highest susceptibility to infection, risk of severe manifestations and lethality rate;

2. in human plasma, the ratio between low molecular weight (LMW) thiols and disulfides and that of proteins declines with age and this also appears to occur in the extracellular fluids of the lung;

3. we hypothesize that these age-dependent changes influence the formation of protein disulfides of CoV-2 spike protein and ACE2 receptor, thus affecting their binding affinity and the risk of severe infection and disease manifestations; The reason(s) standing behind these age-related aspects that differentiate COVID-19 from other pandemic viruses, such as the 1918 pandemic influenza [3] , remain(s) elusive.

An increased susceptibility to oxidative stress with age has been speculated to play a role in this context and several studies in the last months pointed out that a decline of the antioxidant defence systems of the lung, including the glutathione (GSH) and thioredoxin (Trx) systems, act as a possible player in both the ACE-2 receptor-dependent mechanism of the viral infection and the host' capability to respond to the pathogen and its cytopathic and inflammatory effects (for an extensive overview of the literature on these aspects see [4] [5] [6] and references therein). However, the mechanism(s) that stand(s) behind the redox paradigm of COVID-19 infection and its increased virulence with age, remain(s) elusive.

In this hypothesis paper, we suggest that the decline with age of homeostatic mechanisms that control the redox of extracellular low molecular weight (eLMW) thiols could represent the actual causal event and a molecular indicator of the increased risk of infection and development of severe disease.

J o u r n a l P r e -p r o o f

To depict the molecular background of this hypothesis, we recapitulate the receptor-dependent process of the viral infection and the main aspects that characterize its sensitivity to redox processes.

Coronaviruses' tropism is primarily determined by the ability of the spike (S) entry glycoprotein to bind to a cell surface receptor. SARS-CoV-2 binding to the angiotensin-converting enzyme 2 (ACE 2) receptor is identified as the main mechanism of infection to human cells [7] . SARS-CoV and SARS -CoV-2 both possess a trimeric spike S protein with a receptor-binding domain (RBD), which is the actual epitope for the recognition and high-affinity interaction with ACE-2.

Subsequently, the S protein is cleaved by the transmembrane protease serine 2 [8, 9] . One of the reasons for the faster human-to-human diffusion of SARS-CoV-2 with respect to SARS-CoV, lies in the fact that its spike S protein has a 20-fold higher affinity for human ACE2, with a reported Kd of ~15 nM [10] . Biochemical studies show that the infectivity of different SARS-CoV-2 strains in host cells correlates with the binding free energy of the interaction between the respective RBDs and the ACE2 receptor [11] .

The number of ACE2 receptors available for the molecular engagement with the RBDs is another factor that might influence the virus's ability to spread within the host and replicate. However, it is not clear if ACE2 expression directly represents either the infectivity or pathogenicity of the virus [12, 13] . ACE2 is present in lung cells whereas it is rarely expressed in immune cells where other receptors (such as CD147 and CD26) may have a role in mediating virus entry [14] . Worth of note, ACE2 expression in most tissues appears to decline with the host' age [15] and the same is for CD147 in peripheral blood mononuclear cells [14] , which is unexpected from the virus's agedependant virulence. As a consequence, it is reasonable to hypothesize that other age-dependent factors have to intervene in this context.

Aging is associated with progressive decline of homeostatic systems that control the redox balance of all tissues, including the lung tissue, which may explain an increased susceptibility to infections and to develop pulmonary diseases by a defective host response and poor control of inflammatory and fibrotic pathways. These alterations ultimately interfere with tissue repair and regeneration processes, also increasing the risk of viral infections, including SARS-CoV infection. At the same time, a specific disulfide-thiol balance at the viral surface (i.e. of envelope proteins) and at the cellsurface of the host is required for the binding of the virus and for its entry into the cell [4] .

Accordingly, reducing or alkylating agents are reported to disrupt the natural disulfide-thiol balance at the surface of a mature viral envelope of some of these viruses, which may interfere with the J o u r n a l P r e -p r o o f infectious potential [reviewed in [16] ]. This suggests that a pro-oxidant environment at the host cell surface may favor the virus-host cell interaction regardless of the receptor mechanism, thus representing a conserved and efficient mechanism of infection common to different types of infections.

Recent evidence in literature indicated that such thiol to disulfide balance may also influence the protein-protein interaction mechanism of SARS-Cov-2 spike S protein and ACE2 receptor of the host cell [17, 18] . Even if we assume that this Cys residue cannot form intramolecular disulfides, it shouldn't be ruled out that its oxidation to a mixed disulfide might occur during the reaction with eLMW thiols to modify receptor conformation and allosterism as it is demonstrated for several proteins involved in virus-cell interaction [16, 19] .

The fact that some intra-and inter-molecular disulfides in both ACE2 and the SARS-CoV-2 spike RBD seem to have an important role for the infection process [14] let to consider that the binding properties of spike S protein and ACE2 receptor could be regulated by the balance between thiols and disulfides of the extracellular environment. We here discuss how the age-dependent changes in the physiological balance between extracellular thiols and disulfides may have an effect on this process. Our observations can offer a mechanistic explanation for the observed age-related differences in terms of susceptibility to the infection and severity of clinical manifestations in COVID-19 [1].

To shed light on host' factors that affect the redox interaction of proteins involved in COVID-19

infection, extracellular systems able to control the balance of reduced (R-SH) and oxidized (R-SS)

forms of solvent-exposed Cys have to be taken into consideration. These include as main variable J o u r n a l P r e -p r o o f the levels and redox status of LMW thiols [20] . These compounds are key players in the redox buffering of protein Cys being involved in thiol-disulfide exchange reactions. LMW-SH react with protein Cys by nucleophilic attack to a pre-existing disulfide bond [21] following this reaction scheme:

thus, resulting in:

where RSH is a generic LMW-SH, PSH is a protein -SH group, PSSP are inter(intra)-chain protein disulfides and PS-SR are mixed disulfides formed between the protein and LMW thiols. The thiolate form of these species are the actual reacting forms in these equations and the increase or decrease of RSH or RS-SR levels, shifts the equilibrium of reaction (c) towards the right or the left, respectively.

The kinetics and the equilibrium constants of these reactions vary according to the thiols and disulfides involved and the pKa of their Cys residues, i.e. that of the nucleophilic thiol and that of the leaving thiol group. In the case of PSH and inter-chain or intra-chain PSSP, other variables should also be considered, such as entropic barriers and steric hindrance, as well as their dynamics in the reaction milieu [reviewed in [21] ].

LMW thiols/disulfides found in extracellular fluids include as the most abundant and redox-active couples cysteine/cystine (Cys/CySS), cysteinilglycine/cystinilglycine (CysCgly/CysGlySS) and glutathione/glutathione disulfide (GSH/GSSG) (Figure 2 ). In human plasma, the average ratio for these couples is 0.2 and average concentrations of total Cys and total GSH are ~ 200 μM and < 10 μM, respectively [22] [23] [24] . In contrast, GSH is by far the main LMW thiol in cells with concentrations ranging in the different cell types from 1 to 10 mM [25, 26] , while GSH/GSSG ratios range between 200 and 800 [27] . Micromolar concentrations of Cys and other LMW species are present in the cells, and also in these thiols the reduced forms predominate over the oxidized counterparts [28] .

These differences indicate that the cells maintain markedly reducing conditions whereas a more oxidizing environment is encountered extracellularly. Important enough, cellular stressors such as alkylating agents and reactive oxygen species modulate the metabolism of cellular LMW thiols and, consequently, the composition of their extracellular counterparts, which is present in tissues as a ubiquitous and dynamic equilibrium with cell type and disease-specific differences (reviewed in [29] ). Bidirectional transport systems control the levels of Cys and GSH at the two sides of the plasmalemma; a net influx of both Cys and CySS provides the cells of the Cys needed for the J o u r n a l P r e -p r o o f biosynthesis of GSH, whereas the efflux of Cys, GSH and other LMW thiols redistribute these sulfur-containing species in the medium ensuring their availability for other cells and ultimately for the interorgan metabolism of Cys and GSH. Under conditions of cellular stress, a battery of adaptive response genes intervene to control these fluxes and the redox homeostasis of the cell.

These genes affect the synthesis and reduction potential of GSH, and consequently the composition of extracellular LMW thiols, in a compensatory and adaptive manner [28] . Such stress response process is expression of the metabolic and homeostatic competence of tissues, which characteristically decrease with age thus increasing the risk of chronic diseases [30] , as well as of virial infections [31] .

Also, homeostatic processes that maintain the redox state of extracellular thiols decline as a function of the subject' age [22, 32] . Jones at al. described some differences for the redox decline of Cys/CySS and GSH/GSSG couples in plasma, with a linear oxidation of cysteine/cystine redox state over the entire age span, and a linear oxidation of GSH/GSSG that started after approx. 45

years [32] , indicating the capacity of the GSH antioxidant system to compensate for oxidations thanks to metabolic processes that are more efficient in the first part of human lifespan. We also found that the age-dependent decrease of some eLMW SH/SS ratios in the human plasma of healthy subjects, is associated with an increased oxidation of PSH to PS-SR (also referred as to "Protein Thiolation Index" or PTI) (Figure 2, panel D) . These differences in some LMW thiol/disulfide redox couples and their control systems can be explained by the fact that GSH/GSSG predominates and provides control mechanisms within the cells, whereas Cys/CySS predominates in the extracellular fluid [33] . The redox states of these two thiol couples are not in equilibrium with each other and distinct regulatory functions have been proposed, including the direct participation in the interactions with proteins and other LMW thiols to produce opposite situations as far as the balance between thiol and disulfide species is concerned at the two sides of the cell membrane [33] .

In the cells the glycolytic activity of the pentose phosphate pathway (PPP) provides reducing equivalents under the form of NADPH to support the enzymatic activity of glutathione reductase (GR, reaction a) that with other physiological oxidoreductases, such as thioredoxin reductase, maintain the intracellular LMW in the reduced form [29, 34] : d) GSSG + 2NADPH 2GSH + 2NADP + + 2H + (the GR reaction process);

As a result of this reducing environment, intracellularly only a minor fraction of protein Cys (less than 10%) [35] are present as disulfides, with reaction (c) that is shifted to the right being coupled J o u r n a l P r e -p r o o f and subordinate to reaction (d). Therefore, disulfide formation is infrequent and almost all the solvent-exposed Cys residues of intracellular proteins are kept reduced [35] .

Conversely, the extracellular environment lacks of redox-homeostasis systems as efficient as those found in cells and thiol-disulfide exchange reactions are sustained by the activity extracellular oxidoreductases [36] . In the case of plasma, NADPH and GR are present in traces possibly deriving from unspecific release of cellular components during blood drawing and processing of sample for the isolation of plasma; other enzymatic antioxidants such as catalase and glutathione peroxidase, are also present in traces in plasma and other biological fluids [37] . Also the Trx reductase system that plays a major role control of protein Cys redox in cells, does not appear to affect the redox processes of extracellular fluids that present decreased Cys/CySS and GSH/GSSG, and hypothetical protein dithiol-disulfide ratios (PrSH/PrSS) compared with the cytosolic counterpart [33] .

These aspects make disulfide crosslink formation as a more likely process to occur for proteins exposed to the extracellular environment than for intracellular proteins. As an example of this, human serum albumin (HSA), which is by far the most characterized thiol-containing extracellular protein, form mixed disulfides with eLMW thiols (essentially eLMW-SS) that react with Cys34, i.e.

the PTI. Cys34 is the only solvent-exposed Cys residue of HSA that also contains 17 buried disulfides. For example, plasma homocysteine (Hcy) is more than 80 % bound to HSA [38] and also Cys -the main eLMW thiol -forms mixed disulfides with HSA and other eLMW thiols,

including the same Hcy [39] . Cys34 cannot form disulfides with other HSA molecules or other proteins, being located in a partially protected crevice that hampers its reactivity by steric hindrance [40] , but it is known that the thiol-disulfide equilibrium of cellular receptors regulates the binding of HSA [36] , and the same redox mechanism is involved in coronavirus' interaction with the host cell, including the interaction of SARS-CoV-2 with ACE2 receptors in the lung epithelia (discussed earlier).

Therefore, the available data appear to support the notion that to a more oxidized extracellular environment corresponds a higher probability that solvent-exposed Cys residues of proteins result in the formation of intramolecular or intermolecular disulfides with other proteins or eLMW thiols (also referred as to mixed disulfides) and that these redox processes directly influence the SARS-CoV-2 interaction with the host cell (Figure 3 ).

The epithelial surface of the lung varies in adults from 70 to 140 m 2 depending on sex and anthropometric characteristics, and at the same time it contains the largest endothelial surface of any organ. These aspects make this tissue at risk of oxidant damage by the exposure to high oxygen tension during respiration and to a number of environmental oxidants and xenobiotics. Thiols provide an important first line of defence against this pro-oxidant environment; in fact the lung tissue is a major storage area for GSH (6.1-17.5 nmol/mg of tissue) [41] . GSH is released in the lung lining fluid or epithelial lining fluid (LLF or ELF, respectively). It is present in this heterogenous class of extracellular fluids together with other non-enzymatic antioxidants, including

Cys and other LMW thiols. Although GSH levels vary in the different areas of the respiratory tract, being lower in nasal than in alveolar lining fluid [42] , its concentrations in these extracellular fluids range between 100 and 400 μM [43, 44] , which are much (from 10 to 100 fold) higher compared with those found in blood plasma (< 10 μM, commonly between 1 and 6 μM). Moreover, these concentrations have been described to increase by the effect of smoking in the earliest phased of COPD, indicating the presence of an adaptive response of the lung to environmental stressors (tobacco smoke) and the pro-oxidant effects of inflammation (reviewed elsewhere in [45] ). Such response is critical for the antioxidant protection of the lung tissue, and important enough, its efficacy declines with patients' age. In fact, both the levels of GSH in the ELF and the GSH adaptive response to cigarette smoking have been reported to decline in older compared to younger cigarette smokers, with concomitant increase in exhaled nitric oxide [46] ; furthermore, when this age-related decline of the GSH system was investigated in mice, mixed disulfide formation was demonstrated in ELF and lung proteins in association with indices of inflammation and lung emphysema.

Animal studies demonstrate that the lung GSH decreases with age [47] . Moreover, changes in the levels and detoxification function of lung GSH have been reported in several pulmonary diseases and have been associated with pathogenic mechanisms and severity of clinical manifestations that are all age-dependent [45, 48] . Along with the decline of GSH in the ELF of COPD patients with age [46, 49] , changes in the thiol/disulfide balance of extracellular fluids have been described to play a pathogenic role in idiopathic pulmonary fibrosis (IPF), an age-related aliment of the lung caused by the activation of lung fibrinogenesis and oxidative stress [50] . Again, blood plasma thiol/disulphide redox couples decreased with age [22, 32] and smoking [51] , two known risk factors for IPF. This pulmonary disease is characterized by a marked reduction of GSH in blood plasma coupled with increased levels of GSSG, and this reduction is also observed in LLF and induced sputum [reviewed in [45] . Together, these pieces of information prompt the concept that both aging and oxidative stress impair the GSH system of the lung tissue thus interfering with its defense role against the oxidant excess of pulmonary diseases [46, 52, 53] .

The synthesis of GSH depends on the availability of Cys that together with its disulfide CySS, constitute the most abundant LMW thiol/disulfide redox couple of plasma. Unluckily, this redox couple and those of other eLMW thiols have not been investigated in the human lung; however, in the bleomycin model of pulmonary fibrosis, GSH/GSSG and Cys/CySS decreased in plasma during the inflammatory and fibrotic phases of the lung injury, respectively, and a decreased Cys/CySS was also observed in LLF possibly by the decreased food intake that limits the availability of the extracellular Cys [54] . Such experimental data indicate that Cys availability and oxidation contribute to the Cys/CySS redox of extracellular fluids. These aspects of Cys metabolism are also expected to influence the lung metabolism of GSH and the GSH/GSSG ratio of LLF. Accordingly, the administration of N-acetylcysteine (NAC) and other Cys analogues, stimulates the metabolism of GSH in the lung increasing the levels of this tripeptide in LLF and its antioxidant protection function [55] .

The availability of Cys and its redox state in the LLF are also reported to directly influence mucolytic processes. In fact, pharmacological interventions with NAC or other Cys analogues, such as erdosteine and carbocysteine, have been reported modulating Cys oxidation and cross-link formation in mucin polymers thus increasing their solubility [56] . This is not surprising since eLMW thiols participate in mixed disulfides formation with extracellular proteins to eventually interfere with their intra-and inter-molecular interactions (this applies for mucin crosslinks in the LLF as well as for HSA in plasma that was discussed earlier in the previous section). Different from the thiolation processes of lung cells (these are investigated as S-glutathionylation reactions), which can occur both spontaneously and by means of specific enzymatic reactions in the different subcellular compartments [26, 45, 57] , extracellular S-thiolations only occur spontaneously by the activity of nucleophilic eLMW thiols following the same biochemical principles that govern protein thiolation in plasma and other extracellular fluids [25, 58] . In this respect, it is conceivable to assume that similarly to human plasma, solvent-exposed Cys of LLF proteins and extracellular epitopes of lung epithelial cell receptors (including ACE2 receptor) may undergo mixed disulfide formation with eLMW thiols or other proteins (eventually the spike S protein of CoV-2), which depend on LMW thiol availability (essentially Cys intake through the diet) and thiol-disulfide balance of this biological fluid [54] . The dietary intake of Cys, its endogenous formation in the transulfuration pathway, and the redox of LMW thiol couples and PTI in human plasma are all agedependent aspects [59] . These aspects are also reported to affect the thiol redox of LLF and that of extracellular domains of proteins on the lung epithelia.

Here we hypothesize that an age-depended decline of levels and redox balance of LMW thiols in LLF directly promotes protein disulfide formation that is a proposed prerequisite for SARS-CoV-2 virus to bind ACE receptors and infect the host. We base this hypothesis on data in literature that demonstrate close similarities in the reduction of the LMW thiols to disulfides ratio in plasma and LLF. Considering these similarities, oxidation of solvent-exposed Cys residues of both the spike S protein and ACE2 receptor (Figure 1 ) of the lung epithelia, and possibly in other tissues, are more probable as the host' age increases (Figure 3) . In this respect, we suggest that plasma LMW thiols and PTI could be used as surrogate indicators of the age-dependent risk of the host to get infected and to develop severe clinical symptoms. The PTI is robust indicator of impaired redox homeostasis in aging studies first described in our laboratories and now available for extensive application in screening protocols of the general population and high-risk groups, as well as in clinical trials to assess the efficacy of therapies and measures of prevention (vide infra). Such extensive application of the test will also provide the means to verify the present hypothesis and plan for specific interventions.

The verification of our hypothesis is essentially based on thiol analytics and its application to experimental and clinical models. Measuring the redox couples of LMW thiols remains problematic being difficult to avoid pre-analytical oxidations and unspecific formation of mixed disulfides by mobilization of protein-bound thiols and trans-thiolation reactions [60] . Standardized protocols of sample collection and manipulation during the preparation to the analysis have been produced and are routinely utilized in specialized laboratories to prevent such pre-analytical biases; main critical variables are the timing of these steps and the accuracy of sample derivatization to block reactive R-SH of LMW and protein components [22, 23, 27, 61, 62] . Much easier is the analysis of total LMW or protein thiols (reduced and oxidized forms are not distinguished), which are measured after reduction of the analytical sample without preliminary steps of derivatization.

These protocols have been implemented in different types of samples, including biological fluids, cells and tissues (reviewed in [25] ), and for specific applications in large cohorts of patients of clinical trials and screening campaigns of the general population [61, 62] .

In principle, the verification strategy for our hypothesis could be based on in vitro experiments in which changes in the composition and redox of eLMW thiols are introduced by means of different J o u r n a l P r e -p r o o f strategies, while the binding of spike S and ACE-2 is investigated in cell-free experiments or in host cells exposed to CoV2 infection. A first series of these studies has already been planned and is now in progress in our laboratories.

The determination of the fraction of Cys34 of HAS that is S-thiolated at the steady-state (i.e.

involved in the formation of mixed disulfides with eLMW-SS), also referred as to PTI (Figure 2 and 3), could be utilized as a useful verification tool of this hypothesis in clinical trials. This is a reliable index of the redox equilibrium between LMW and protein thiols of extracellular fluids, and an indicator of oxidative stress [58, 61, 62] . Its levels linearly increase with the subject age mirroring the increased susceptibility of plasma proteins to undergo S-thiolation during aging by the impaired thiol/disulfide status of eLMW species [63] (Figure 2) . Because sufficient evidence is available in literature to assert that the age-and lung disease-dependent modifications of thiol/disulphide redox can be evaluated with the PTI, this laboratory test could directly be applied in clinical trials to test with an "a priori" approach if increased levels of this indicator correlate with the risk of infection and severity of its manifestations. This type of study could easily be planned in collaboration with CoV-2 diagnostic centers.

In verifying this hypothesis, it is important to consider that thiol concentrations and oxidation state of extracellular fluids depend on a rather complex series of factors that are all independently affected by the aging process, the main ones include: i) the dietary intake of cysteine [59] , ii) the transmembrane flux of cellular thiols that is important to sustain the biosynthesis and efflux of GSH in the lung [45] and also to control signal transduction throughout adaptive stress response and programmed cell death pathways [28] , iii) the metabolism of circulating GSH by the γglutamyltranspeptidase (γ-GT) activity of tissues and especially of the kidney [64, 65] .

All these aspects (the quality of nutrition, the efficacy of the adaptive stress response and kidney function) and their decline with the age are among the risk factors for severe manifestations and risk of death in CoV-2 patients. Therefore, it is not surprising that these aspects are among the main variables that one should consider to design and implement rationalized strategies of prevention and protection from COVID-19 in the elderly [66] . Their clinical relevance in relationship with thioldisulfide balance of extracellular fluids can be inferred by the study of different age-related ailments [64] , including chronic kidney disease (CKD) that has previously been investigated in our laboratories. This condition causes a very severe form of premature aging and secondary immune dysfunction [67] , and therefore it is not surprising that these patients have a markedly higher risk of severe complications and mortality once exposed to CoV-2 infection [68] . Along with an impaired J o u r n a l P r e -p r o o f renal metabolism of thiols, these patients present severe protein-caloric malnutrition and increased protein catabolism, and chronic exposure to retention solutes and pro-inflammatory mediators that ultimately interfere with the stress adaption response of tissues and thiol-disulfide balance of blood plasma, and increased levels of PTI [24, 69, 70] . A reduced or absent function of tubular epithelia cells that express high levels of γ−GT enzyme protein is observed in the late stages of the diseases, and recent studies by our group suggest that the activity of this enzyme is important to control both the renal metabolism and extracellular levels of LMW thiols [65] .

A trend toward a decrease of circulating S-thiolated proteins in healthy subjects during spring and summer was also observed in our laboratories [62] , which is another factor to consider in the verification strategy to assess host' susceptibility to CoV-2 infection in relationship with factors that may influence the extracellular redox.

Gender differences should also be investigated being significantly higher the age-dependent risk of severe complications and mortality in male compared to female CoV-2 patients [71] . Although the thiol to disulphide balance of plasma does not appear to be under the influence of gender [22, 32] , the decline with age of GSH/GSSG, but not that of Cys/CySS, appears to differ in male compared with female [32] , and the same has been reported for the blood levels of total GSH in some studies on age-related diseases (recently reviewed in [72, 73] ).

Another aspect to consider for the verification of the hypothesis proposed in this study, is the role of pharmacological and/or nutritional treatments that are supposed to target extracellular LMW thiols.

This type of verification could be performed in ongoing clinical trials and among the registered studies, and consultable at www.clinicaltrials.org, some are based on treatments with LMW-SH (NAC, GSH or bucillamine). All these studies are essentially aimed at limiting the damages of acute inflammation (cytokine storm) rather than preventing the virus-host cell interaction and thus the infection in the respiratory tract. This is quite surprising to us because LMW-SH are not very efficient agents in acute inflammation. Nevertheless, a bounce of studies reports these treatments may result in better clinical outcomes [74, 75] , thus suggesting more complex effects than simple anti-inflammatory.

Timing of the intervention with chemo-protection and prevention agents is crucial as it is for antiviral agents. Although the time-course of virus infection and the extent of the viral load differ between patients, the available evidence suggests that the viral load peaks around symptom onset and decreases from one to three weeks after this step of the infectious disease [76] . In this context, a protection or even early-phase prevention treatment with LMW-SH is difficult to plan and in fact it J o u r n a l P r e -p r o o f has never been implemented in clinical trials so far for subjects at risk of infection or disease complications. However, in the future, several currently FDA-approved drugs could be taken into consideration for this purpose, including NAC, GSH, sodium methanethiolate (Mesna), thiopronine, bucillamine, anethole dithiolethione [55, 75, [77] [78] [79] . The established safety profile of these drugs that are already in use to treat other pathologies, suggest that these could be utilized even at high doses and for long-lasting treatments [80] [81] [82] [83] [84] [85] .

Increasing thiol/disulfide ratio in the extracellular milieu by a higher intake of antioxidants (not only of sulfur-containing molecules), is another option to consider for the verification of our hypothesis. Dietary or pharmacological antioxidants, are assumed to counteract the toxic effect of electrophiles that are often identified with the generic definition of reactive oxygen species. Such definition suggests that this class of compounds could indirectly increase the thiol/disulfide ratio of extracellular fluids. However, a very small number of studies, have explored the effects of antioxidants on extracellular thiols with unbiased analytical procedures, which are essential to accurately determine their concentrations and redox [86, 87] . This is a major lack of knowledge that leaves open-up to further verification the opportunity to use the different groups of molecules that fall in this wide category of active ingredients in chemo-protection or prevention measures.

A more direct approach can be represented by the treatment with physiological sulfur-containing amino acids. Jones et al. [59, 88] reported an increased Cys/CySS ratio after a normal meal supplemented with methionine and cysteine. Also, whey proteins appear to produce the same results, being rich in cysteine [89] . Food items reach in thiol compounds, such as GSH and cysteine (e.g. asparagus, avocado, and spinach are rich in GSH, and red pepper and asparagus are rich in cysteine) can be utilized to increase the serum levels of Cys [90] . Moreover, there is general agreement on the fact that a higher intake of fruit and vegetables rich in phenolics and other electrophilic bioactives can increase the antioxidant levels in plasma, also affecting extracellular thiols, possibly by the stimulation of hepatic detoxification genes that include those of GSH biosynthesis and GSH-dependent phase II enzymes [91] . For example, soy isoflavons utilized as functional ingredients in food have been demonstrated to increase the plasma levels of free thiols while improving insulin function in type 2 diabetic patients [92] . Nrf2 activators, such as seleniumcontaining agents [28] , and sulforaphane, resveratrol and many others (reviewed in [31] ), are also reported to increase the cellular biosynthesis of GSH and sustain its reduction and extracellular availability by induction of membrane transport genes that control its efflux as part of the detoxification response found in virtually all cells. The effects of these food-derived antioxidants and detoxification compounds on the levels and redox status of extracellular LMW thiols and PTI remain unexplored.

J o u r n a l P r e -p r o o f

In summary, the take home message of the present hypothesis paper is that, if the binding of the spike S protein to ACE2 receptor of the host cell depends on conformational changes of these proteins by the formation of protein disulfide (Figure 1) , the thiol-disulfide ratio of LMW thiols in LLF must be a direct player of the process. In fact, the formation of mixed and intramolecular disulfides on solvent-exposed Cys of these proteins will be the results of the presence of sufficient oxidizing conditions that lower this ratio in eLMW thiols (Figure 3) . Despite the widely recognized role of the GSH system in the redox homeostasis of the respiratory tissues, the role of eLMW thiols in COVID-19 infection has been ignored so far. The age-dependent decline of the GSH system of the lung and other tissues, and the impaired control of the thiol to disulfide balance of the extracellular fluids, including the LLF, offer a convincing mechanism for an increased risk of severe clinical manifestations in this viral infection. Herein we propose to assess such mechanistic interpretation in experimental models of COVID-19 infection (this is to assess the redox principles of the hypothesis) and in clinical trials (this is to confirm the age-dependence and the clinical relevance of the hypothesis). To provide a realistic verification strategy for our hypothesis, a standardized laboratory procedure for the microanalysis of PTI in human blood, has recently been developed [62] and it is now available for the screening of the general population and groups at risk protein interface is proposed to produce conformational changes that decrease binding affinity [17, 18] . The figure was drawn using PDB entry 6M0J. 

Age-dependent effects in the transmission and control of COVID-19 epidemics

The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review

Oxidative Stress Associated with SARS-Cov-2 (COVID-19) Increases the Severity of the Lung Disease -A Systematic Review

Tissue damage from neutrophil-induced oxidative stress in COVID-19

A pneumonia outbreak associated with a new coronavirus of probable bat origin

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Mutations Strengthened SARS-CoV-2 Infectivity

Manipulation of ACE2 expression in COVID-19. Open Heart

Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science

Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus

Conformational Perturbation of SARS-CoV-2 Spike Protein Using N-Acetyl Cysteine, a Molecular Scissor: A Probable Strategy to Combat COVID-19

Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor

Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope

The role of thiols in antioxidant systems

From structure to redox: The diverse functional roles of disulfides and implications in disease

Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma

Measuring the poise of thiol/disulfide couples in vivo

Blood thiol status and erythrocyte glutathione-S-transferase in chronic kidney disease patients on treatment with frequent (daily) hemodialysis

Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells

Glutathione compartmentalization and its role in glutathionylation and other regulatory processes of cellular pathways

Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures

Glutathione S-transferase P influences the Nrf2-dependent response of cellular thiols to seleno-compounds

Targeting glutathione S-transferase P and its interactome with selenium compounds in cancer therapy

The role of declining adaptive homeostasis in ageing

Can Activation of NRF2 Be a Strategy against COVID-19?

Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses

Radical-free biology of oxidative stress

Global methods to monitor the thiol-disulfide state of proteins in vivo

Quantifying the global cellular thiol-disulfide status

Thiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment

The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase

The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels

Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation

Covalent binding between bucillamine derivatives and human serum albumin

Lung glutathione and oxidative stress: implications in cigarette smokeinduced airway disease

Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect

Normal alveolar epithelial lining fluid contains high levels of glutathione

Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids

Endoplasmic reticulum stress and glutathione therapeutics in chronic lung diseases

Glutathione Depletion Accelerates Cigarette Smoke-Induced Inflammation and Airspace Enlargement

Low molecular mass thiols, disulfides and protein mixed disulfides in rat tissues: influence of sample manipulation, oxidative stress and ageing

Oxidative stress and antioxidant therapy in cystic fibrosis

Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung

Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis

Oxidation of glutathione and cysteine in human plasma associated with smoking

Age-dependent dysregulation of redox genes may contribute to fibrotic pulmonary disease susceptibility

Aging-related decline in the induction of Nrf2-regulated antioxidant genes in human bronchial epithelial cells

Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis

Maestra Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19

Oxidation increases mucin polymer cross-links to stiffen airway mucus gels

Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress

Protein thiolation index (PTI) as a biomarker of oxidative stress

Dietary sulfur amino acid effects on fasting plasma cysteine/cystine redox potential in humans

Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG) in biological samples: An elephant in the room

Determination of protein thiolation index (PTI) as a biomarker of oxidative stress in human serum

Protein thiolation index in microvolumes of plasma

Extracellular redox state: refining the definition of oxidative stress in aging

Extracellular thiols and thiol/disulfide redox in metabolism

Anethole Dithiolethione Increases Glutathione in Kidney by Inhibiting

Lifestyle lessons from the COVID-19 pandemic. PharmaNutrition

Inflammation and Premature Ageing in Chronic Kidney Disease

COVID-19 and the Kidneys: An Update

Dietary Intake of Proteins and Calories Is Inversely Associated With The Oxidation State of Plasma Thiols in End-Stage Renal Disease Patients

Plasma protein thiolation index (PTI) as a biomarker of thiol-specific oxidative stress in haemodialyzed patients

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis

Uncovering sex-specific mechanisms of action of testosterone and redox balance

Sexual dimorphism in glutathione metabolism and glutathionedependent responses

Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients

Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent

Dithiolethiones for cancer chemoprevention: where do we stand? Mol Cancer Ther

Bucillamine in Treatment of Patients With COVID-19

Clinical pharmacokinetics of N-acetylcysteine

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis

Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion

Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man

The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study

A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia

Comprehensive plasma thiol redox status determination for metabolomics

Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction

Postprandial cysteine/cystine redox potential in human plasma varies with meal content of sulfur amino acids

Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study

A Review of Dietary (Phyto)Nutrients for Glutathione Support

Interactions of polyphenolic compounds with drug disposition and metabolism

Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes. Diabetes Care

The authors have no conflicts of interest to declare.